While insulin secretion was enhanced in typical cases of Cushing's syndrome and steroid-induced diabetes, it is plausible to speculate that GR-regulated NECAB1 expression in β-cells may have a pathophysiological role in diabetes development in some stages of the disease. This evidence concerns the gene NECAB1 and Cushing syndrome.